Insmed (INSM)
(Delayed Data from NSDQ)
$24.80 USD
-0.12 (-0.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.50 -0.30 (-1.21%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Insmed, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -749.57 | -481.53 | -434.65 | -294.09 | -254.34 |
Depreciation/Amortization & Depletion | 20.61 | 16.28 | 46.30 | 35.61 | 29.92 |
Net Change from Assets/Liabilities | -39.22 | 6.58 | -58.58 | -2.95 | -62.97 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 231.93 | 58.24 | 83.63 | 42.09 | 36.73 |
Net Cash From Operating Activities | -536.25 | -400.44 | -363.30 | -219.35 | -250.65 |
Property & Equipment | -13.29 | -9.88 | -7.29 | -6.24 | -42.27 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -6.70 | 0.00 | 0.00 |
Investments | -213.73 | -24.71 | -50.29 | 0.00 | 0.00 |
Other Investing Activities | 3.42 | 0.00 | 0.00 | -0.58 | 0.00 |
Net Cash from Investing Activities | -223.60 | -34.58 | -64.29 | -6.82 | -42.27 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 170.87 | 311.66 | 291.92 | 271.94 | 280.78 |
Issuance (Repayment) of Debt | 0.00 | 350.00 | 337.42 | -0.94 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.44 | 131.62 | -16.80 | 0.00 | 4.50 |
Net Cash from Financing Activities | 168.44 | 793.27 | 612.55 | 271.00 | 285.28 |
Effect of Exchange Rate Changes | -0.25 | -1.00 | -0.93 | 0.49 | 0.00 |
Net Change In Cash & Equivalents | -591.66 | 357.25 | 184.03 | 45.33 | -7.64 |
Cash at Beginning of Period | 1,074.04 | 716.78 | 532.76 | 487.43 | 495.07 |
Cash at End of Period | 482.37 | 1,074.04 | 716.78 | 532.76 | 487.43 |
Diluted Net EPS | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 |
Fiscal Year End for Insmed, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -749.57 | -563.51 | -404.57 | -159.76 |
Depreciation/Amortization & Depletion | NA | 20.61 | 15.44 | 10.17 | 4.91 |
Net Change from Assets/Liabilities | NA | -39.22 | -46.89 | -22.92 | -20.74 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 231.93 | 189.52 | 148.23 | 29.29 |
Net Cash From Operating Activities | NA | -536.25 | -405.43 | -269.10 | -146.30 |
Property & Equipment | NA | -13.29 | -11.14 | -8.28 | -3.40 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -213.73 | -217.69 | -227.69 | 45.00 |
Other Investing Activities | NA | 3.42 | 3.42 | 3.42 | 0.00 |
Net Cash from Investing Activities | NA | -223.60 | -225.41 | -232.55 | 41.60 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 170.87 | 48.78 | 46.44 | 1.14 |
Issuance (Repayment) of Debt | NA | 0.00 | -2.38 | -1.29 | -0.32 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -2.44 | -1.22 | -1.22 | -1.22 |
Net Cash from Financing Activities | NA | 168.44 | 45.18 | 43.93 | -0.40 |
Effect of Exchange Rate Changes | NA | -0.25 | -1.26 | -3.43 | -0.03 |
Net Change In Cash & Equivalents | NA | -591.66 | -586.92 | -461.15 | -105.13 |
Cash at Beginning of Period | NA | 1,074.04 | 1,074.04 | 1,074.04 | 1,074.04 |
Cash at End of Period | NA | 482.37 | 487.11 | 612.88 | 968.91 |
Diluted Net EPS | NA | -1.28 | -1.11 | -1.78 | -1.17 |